Adding glimepiride to insulin+metformin in type 2 diabetes of more than 10 years’ duration—A randomised, double-blind, placebo-controlled, cross-over study-Reference-Cited by-同舟云学术

Adding glimepiride to insulin+metformin in type 2 diabetes of more than 10 years’ duration—A randomised, double-blind, placebo-controlled, cross-over study

Published:2014-02 Issue:2 Volume:103 Page:286-291
ISSN:0168-8227
Container-title:Diabetes Research and Clinical Practice
language:en
Short-container-title:Diabetes Research and Clinical Practice

Author:

Nybäck-Nakell Å.,Adamson U.,Lins P.E.,Landstedt-Hallin L.

Publisher

Elsevier BV

Subject

Endocrinology,General Medicine,Endocrinology, Diabetes and Metabolism,Internal Medicine

Reference33 articles.

1. U.K. prospective diabetes study 16. Overview of 6 years’ therapy of type II diabetes: a progressive disease;U.K. Prospective Diabetes Study Group;Diabetes,1995

2. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33);U.K. Prospective Diabetes Study Group;Lancet,1998

3. Glycaemic responsiveness to long-term insulin plus sulphonylurea therapy as assessed by sulphonylurea withdrawal;Nyback-Nakell;Diabetic Med,2007

4. Addition of biphasic, prandial, or basal insulin to oral therapy in type 2 diabetes;Holman;N Engl J Med,2007

5. Performance evaluation of the MiniMed continuous glucose monitoring system during patient home use;Gross;Diabetes Technol Ther,2000

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Clinical Evidence and Practice-Based Guidelines on the Utility of Basal Insulin Combined Oral Therapy (Metformin and Glimepiride) in the Current Era;Current Diabetes Reviews;2023-10

2. Optimization of Potential Nanoemulgels for Boosting Transdermal Glimepiride Delivery and Upgrading Its Anti-Diabetic Activity;Gels;2023-06-18

3. Real-World Observational Study of Glimepiride and Metformin Fixed-Dose Combination Along With Insulin in the Management of Type 2 Diabetes Mellitus: Indian Experience;Cureus;2021-01-30

Beta-cell function in type 2 diabetic patients who failed to maintain good glycemic status with a combination of maximum dosages of metformin and sulfonylurea

;Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy;2019-05

5. Do sulphonylureas still have a place in clinical practice?;The Lancet Diabetes & Endocrinology;2018-10